Company Valuation: DataMEDS AI, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2025
Market Cap 1 40.08
Change -
Enterprise Value (EV) 64.63
Change -
P/E -0.28x
PBR -3.25x
PEG -0x
Capitalization / Revenue 1,717,555x
EV / Revenue -
EV / EBITDA -
EV / EBIT -0x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 -71.33
Distribution rate -
Net sales 23.34
EBITDA -77.98
EBIT 1 -81.19
Net income 1 -101.3
Net Debt 24.54
Reference price 2 19.975
Nbr of stocks (in thousands) 2,007
Announcement Date 3/20/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 8.82M
32.9x5.76x22.06x0.28% 245B
37.02x6.61x20.93x0.65% 154B
44.64x11.9x26.26x-.--% 146B
15.72x3.26x10.63x-.--% 60.26B
34.5x6.77x21.5x-.--% 49.44B
32.93x6.52x22.13x0.61% 47.67B
18.96x2.31x11.7x2.66% 48.04B
43.25x10.48x23.1x-.--% 45.74B
76.33x7.23x22.01x-.--% 42.84B
Average 37.36x 6.76x 20.04x 0.47% 83.88B
Weighted average by Cap. 36.55x 7.04x 21.20x 0.39%

Y-o-Y evolution of P/E

Valuation ratios - P/E - DataMEDS AI, Inc.

Historical PBR trend

Valuation ratios - PBR - DataMEDS AI, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - DataMEDS AI, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - DataMEDS AI, Inc.

  1. Stock Market
  2. Stocks
  3. MEDS Stock
  4. Valuation DataMEDS AI, Inc.